{"name":"Moderna, Inc.","slug":"moderna","ticker":"MRNA","exchange":"NASDAQ","domain":"modernatx.com","description":"Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, including propionic and methylmalonic acidemia, and cystic fibrosis. It has strategic alliances and collaborations with Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; immatics N.V.; Defense Advanced Research Projects Agency; Biomedical Advanced Researc","hq":"Cambridge, MA","founded":2010,"employees":"4700","ceo":"Stéphane Bancel","sector":"Biotech","stockPrice":50.52,"stockChange":0.1,"stockChangePercent":0.2,"marketCap":"$20.0B","metrics":{"revenue":2224999936,"revenueGrowth":260.2,"grossMargin":-69.9,"rdSpend":0,"netIncome":-3193999872,"cash":5205000192,"dividendYield":0,"peRatio":-12.1,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2025-06-01","label":"COVID-19 Vaccine patent cliff ($1.5B at risk)","drug":"COVID-19 Vaccine","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2023-12-14","type":"regulatory","headline":"Moderna Receives FDA Approval for COVID-19 Vaccine Update","summary":"Moderna announced that the FDA has approved its updated COVID-19 vaccine, which provides protection against the Omicron variant.","drugName":"COVID-19 Vaccine","sentiment":"positive"},{"date":"2023-11-07","type":"earnings","headline":"Moderna Reports Third Quarter 2023 Financial Results","summary":"Moderna reported revenue of $2.4 billion for the third quarter of 2023, exceeding analyst expectations.","drugName":"","sentiment":"positive"},{"date":"2023-09-12","type":"deal","headline":"Moderna Partners with Pfizer to Develop mRNA-Based Flu Vaccine","summary":"Moderna announced a partnership with Pfizer to develop an mRNA-based flu vaccine, which will be used to combat seasonal flu outbreaks.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9wWURXRkdkRl9mdE9QYW1tZThhSndEMTdZYzJ2LWFMbXlyeWtwZmthaEVxbmF1eVVtYms0MUNRUmhsdkV3QWtRRi1NbE43SEdrbG5SeTdraEdNRWNlcUp0RzByVzZpMWVMSTBVR3ln?oc=5","date":"2026-04-03","type":"pipeline","source":"Investopedia","summary":"Top Moderna Shareholders - Investopedia","headline":"Top Moderna Shareholders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQS3ZGSkgtTy1JVGNjOXh1QlEzUU93azl5XzRIRUt3Z0E0bmFRdUtaV0xDOWg3Ui01Wm9JcTVsZnFkYmVTSWlTZzVjVDVJa1I2V084V1lrdE1iOUNBYWlEaXRpbTdINzBEeklDX2RDTDlqaFV2NjA3RXpTRHRLV3F0QkxBdTV2STg?oc=5","date":"2026-03-13","type":"pipeline","source":"JD Supra","summary":"Quo Vadis mRNA Vaccine Technology? The State of the IP Lawsuits - JD Supra","headline":"Quo Vadis mRNA Vaccine Technology? The State of the IP Lawsuits","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOWDZlRWJmd1JMdEdjREZpQU5WZWN0OW1SUXJGRngwV1UzZFJ4cVRqbjlrNFdra292YU1tT080RnJKQlhDUHUxSEQwSzlORjBKYzNSS0diNFFTVmRybFF4ajY0NHkzSHU5UGNQTmI5N1NyaE9GQWxkOEdEUUJrbmxaSV9jQi1XOHNMREFNaUpjXzUtZ2dMOXVZeEc3d2pfUDctb2VYTzg0ZU5TY2NNa0hfLXdJZw?oc=5","date":"2026-02-18","type":"regulatory","source":"Contract Pharma","summary":"U.S. FDA to Initiate Review of Moderna’s Investigational mRNA Flu Vax - Contract Pharma","headline":"U.S. FDA to Initiate Review of Moderna’s Investigational mRNA Flu Vax","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQZ0NCMnBmRndkNHBwVXFGNzkxY3Z3MWVGOE1feXN1SGxPNGdBdTlocVdNMFdzam9XQ0J6LTltdUd4TGttQjhFVHctTVJTN2w1eUNqODVTazVhRXBveFVXVlFIYVIyUU9CdmFwRm1ZRG9vUFRpZjJNOGNSTElrQndPNmc2N0EzcGh6SHFQUUdmWUc4bTJUb2lzWW0zYldSOGotMlhROEVHMmdVVHJLckZOMHoxdC1Ndw?oc=5","date":"2026-02-13","type":"earnings","source":"TradingView","summary":"Moderna Q4 Loss Narrower-Than-Expected, Sales Beat Estimates - TradingView","headline":"Moderna Q4 Loss Narrower-Than-Expected, Sales Beat Estimates","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOanVJLWFJOGxkV3FvbzdMR0RUYUFoS3dCa2NvZktZMV8xa09URC1tWkVyekI2Zk8xV21iX1ZUTl9VekNiRHJnVUZ3MXRQZWM4V29UUHo0eXdaelJnLUpXY3Fpc3Y2eWRQdUFkTEJQTkdybGluLTNLcFhoSnVTVThrM1pQRnJIY0J0bkhUNmhsVUdDOHMxVU9xTERZOFpxNEE2cHlfSWRhZFZVY0t5VDY2MVYzeGppS2c?oc=5","date":"2026-02-11","type":"pipeline","source":"Pharmaceutical Technology","summary":"Mexico enlists Moderna to boost mRNA supply for respiratory diseases - Pharmaceutical Technology","headline":"Mexico enlists Moderna to boost mRNA supply for respiratory diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxQRzcwRFVSY2h3Si1uQzZmOXFGaWllMUtDbmlqWnBTUE5IUmx1QXpOWlhsWUFsQmh5cDFLOWl4Sld6RGNYQXpLVDVJZk1oUVV4dHRSVHNjUnJqYURlb1ZiQ3hjN2RCdGNWZmFiS0o4R1pQSXhReE84QUd3ZTdqc2ZiWGhB?oc=5","date":"2026-02-04","type":"pipeline","source":"Yahoo Finance","summary":"Jim Cramer on Moderna: “Even Though the Stock’s on the Mend, There Are Many Pharma and Biotech Names That I Like Better” - Yahoo Finance","headline":"Jim Cramer on Moderna: “Even Though the Stock’s on the Mend, There Are Many Pharma and Biotech Names That I Like Better”","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOd0w0Q2dIbUlmb2hXNHdSM2hCWDJ6SHFXM0ZlUDBzU1RkeU1PUGE3RlFFMzg4SHBDTWlEYXdWZTkwRDJDWUpUR0dsYjZJYkl5eklFWDdaeUpxZkhDM2FxUXpHbFdqVnVsTmltVll5UjlXeTUxZUlBdG5GVk15MlcwLVdIeHhCVUZvYk80QXNJSlN5cmtKNjd3Nm0zOA?oc=5","date":"2025-12-11","type":"deal","source":"Pharmaceutical Technology","summary":"Moderna signs deal worth up to $503m with Nanexa - Pharmaceutical Technology","headline":"Moderna signs deal worth up to $503m with Nanexa","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNMzdtTG9YQl9ydVZ6eTVpZDFZOENOUUoyT2o1QW04dklFd28xVHBQQktkNkNwZWpMQ1lXeThpZEI0RTVDREdXQkotajV2NnZnLVRISEVHVHVIcVY1MkhMUEpmWXY3b19hSXc1WENLbUwwVXA5ekNlVHdRdHRubjFiT2pJdmI4aC1PM2dzYXN0ekZZYkd2dGQ3VG9RS1Y0U2o0S1lyQkJpWDVlUU9rbHJCOHBjMm1janBfcnc?oc=5","date":"2025-11-20","type":"pipeline","source":"Fierce Pharma","summary":"Moderna takes out $1.5B loan, outlines commercial and R&D strategy in bid to break even by 2028 - Fierce Pharma","headline":"Moderna takes out $1.5B loan, outlines commercial and R&D strategy in bid to break even by 2028","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxNOGxNeE5uNGw0WDFsNFJvRHBiRTFOQzlTLU1YekVLNVNqeEVjdy1yVHBfVzJEalBDV0J0ODJUcHJPbWt6YzdGSDhYQXp6OXk1dDkzZTBEbnlFbHIwSjdpYTJia0lkbHBoMzdacXdHZ3pNYVI0cjBKdjlobDZ2c2NHMWtfUEM2QlRLQndfLVhYbTBKTlFqeWVYWTRwcEV6VjVYN2ZKamVtT29pUzFqODZhMVN4MDY2UUc4NHl3VTQxS3RTbWQ3UDFZdW5vZklSR2JTbEhIUUpjZVZzODlvaWtv?oc=5","date":"2025-11-19","type":"pipeline","source":"Reuters","summary":"Moderna to complete US mRNA manufacturing network with $140 million investment - Reuters","headline":"Moderna to complete US mRNA manufacturing network with $140 million investment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxQRVFOYlFGX01JaDBiMWxxZEFFc0NFeVEwVUEyMFk3VjMtcXFBLUd3R0tWQS1NU29KRTlZN2Iwd3FKRWlGYzlKMkFqbGMzRGd6aU9mSHg0cHpvMkFka28tN3d0RVg0WUNKT3NnM00yOXN1MzMwVDdGQkxuNnEySVdCOWVTc1IwT3JwZUJyOGxKaExFWHVUWjY5dFFIbkpPUkU0enVKd1piOV92c2k1QnpmUU15LTFHam40WVR1bEkyVTdEd0JTdl9Yamh3?oc=5","date":"2025-09-25","type":"pipeline","source":"The Guardian","summary":"Moderna boss defends UK in drug-pricing row as he opens £150m Oxfordshire facility - The Guardian","headline":"Moderna boss defends UK in drug-pricing row as he opens £150m Oxfordshire facility","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNVE56U2ZITkNvRVdETTNHVE5zQmI1cWVwcVZjR1o0UVRhMEpFUzFRV0U4TGpjUzNhRVR1ZjNfS2VZZk9naXJmdmt6bXRTNGdVZnloMEhqU1BhYmswX2NsdHZpYXhHOGYtRGp0aDViMGtDQllrR1d1RkVFdVFXLVhJeHcwcVdPdHpzdG1Dc3N2U0E3Y3otNWJFUTZ6Tmw?oc=5","date":"2025-09-15","type":"pipeline","source":"Pharma Voice","summary":"Moderna and BioNTech pioneered mRNA vaccines. But who will make a mark in therapeutics? - Pharma Voice","headline":"Moderna and BioNTech pioneered mRNA vaccines. But who will make a mark in therapeutics?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxPbGxydjZxRUphTTBpY1RGM3NUeUNQS1ZyNi1FVkRYaVdqZ2diZ0RVOXBaYUZGTEdIRXFqVjdPTHRscE9FOFByaE5OREdRcFM3ZnpaeGE1Z1pvM0FhX1NsamJITENNclRhUjdESkxnckF6YkcwclFVVEpKOHZlMExYSGI5RVZFMjg?oc=5","date":"2025-08-06","type":"pipeline","source":"BioSpace","summary":"RFK Jr. Axes 22 mRNA Vaccine Projects Under BARDA - BioSpace","headline":"RFK Jr. Axes 22 mRNA Vaccine Projects Under BARDA","sentiment":"neutral"}],"patents":[{"drugName":"COVID-19 Vaccine","drugSlug":"mrna-1273","patentNumber":"","type":"Patent Cliff","expiryDate":"2025-06-01","territory":"US","annualRevenue":1500000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":3,"keyCompetitors":["BioNTech","Pfizer","Johnson & Johnson"],"therapeuticFocus":["Infectious Diseases","Cancer"],"financials":{"source":"yahoo_finance","revenue":1922000000,"revenuePeriod":"2025-12-31","revenueHistory":[{"period":"2025-12-31","value":1922000000},{"period":"2024-12-31","value":3199000000},{"period":"2023-12-31","value":6754000000},{"period":"2022-12-31","value":18875000000}],"grossProfit":1054000000,"grossProfitHistory":[{"period":"2025-12-31","value":1054000000},{"period":"2024-12-31","value":1735000000},{"period":"2023-12-31","value":2061000000},{"period":"2022-12-31","value":13459000000}],"rdSpend":3132000000,"rdSpendHistory":[{"period":"2025-12-31","value":3132000000},{"period":"2024-12-31","value":4543000000},{"period":"2023-12-31","value":4845000000},{"period":"2022-12-31","value":3295000000}],"sgaSpend":1018000000,"operatingIncome":-3074000000,"operatingIncomeHistory":[{"period":"2025-12-31","value":-3074000000},{"period":"2024-12-31","value":-3945000000},{"period":"2023-12-31","value":-4239000000},{"period":"2022-12-31","value":9420000000}],"netIncome":-2822000000,"netIncomeHistory":[{"period":"2025-12-31","value":-2822000000},{"period":"2024-12-31","value":-3561000000},{"period":"2023-12-31","value":-4714000000},{"period":"2022-12-31","value":8362000000}],"eps":-9.28,"epsHistory":[{"period":"2024-12-31","value":-9.28},{"period":"2023-12-31","value":-12.33},{"period":"2022-12-31","value":20.12},{"period":"2021-12-31","value":28.29}],"cash":2595000000,"cashHistory":[{"period":"2025-12-31","value":2595000000},{"period":"2024-12-31","value":1927000000},{"period":"2023-12-31","value":2907000000},{"period":"2022-12-31","value":3205000000}],"totalAssets":12338000000,"totalLiabilities":3688000000,"totalDebt":1305000000,"equity":8650000000,"operatingCashflow":-1873000000,"operatingCashflowHistory":[{"period":"2025-12-31","value":-1873000000},{"period":"2024-12-31","value":-3004000000},{"period":"2023-12-31","value":-3118000000},{"period":"2022-12-31","value":4981000000}],"capex":-202000000,"capexHistory":[{"period":"2025-12-31","value":-202000000},{"period":"2024-12-31","value":-1051000000},{"period":"2023-12-31","value":-707000000},{"period":"2022-12-31","value":-400000000}],"freeCashflow":-2075000000,"dividendsPaid":null,"buybacks":0,"employees":4700,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":173000000,"ebit":-1317000000,"ebitda":-1258000000,"period":"2026-03-31","revenue":389000000,"epsBasic":-3.4,"netIncome":-1343000000,"rdExpense":649000000,"epsDiluted":-3.4,"grossProfit":-566000000,"operatingIncome":-1388000000},{"sga":308000000,"ebit":-791000000,"ebitda":-724000000,"period":"2025-12-31","revenue":676000000,"epsBasic":-2.11,"netIncome":-826000000,"rdExpense":775000000,"epsDiluted":-2.11,"grossProfit":224000000,"operatingIncome":-857000000},{"sga":268000000,"ebit":-187000000,"ebitda":-135000000,"period":"2025-09-30","revenue":1002000000,"epsBasic":-0.51,"netIncome":-200000000,"rdExpense":801000000,"epsDiluted":-0.51,"grossProfit":795000000,"operatingIncome":-260000000},{"sga":230000000,"ebit":-817000000,"ebitda":-760000000,"period":"2025-06-30","revenue":137000000,"epsBasic":-2.13,"netIncome":-825000000,"rdExpense":700000000,"epsDiluted":-2.13,"grossProfit":18000000,"operatingIncome":-907000000},{"sga":212000000,"ebit":-963000000,"ebitda":-924000000,"period":"2025-03-31","revenue":107000000,"epsBasic":-2.52,"netIncome":-971000000,"rdExpense":856000000,"epsDiluted":-2.52,"grossProfit":17000000,"operatingIncome":-1050000000},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-12-31","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":50.52,"previousClose":50.42,"fiftyTwoWeekHigh":59.55,"fiftyTwoWeekLow":22.28,"fiftyTwoWeekRange":"22.28 - 59.55","fiftyDayAverage":51.61,"twoHundredDayAverage":36.39,"beta":1.06,"enterpriseValue":16098963456,"forwardPE":-12.1,"priceToBook":2.3,"priceToSales":9.01,"enterpriseToRevenue":7.24,"enterpriseToEbitda":-7,"pegRatio":0,"ebitda":-2299000064,"ebitdaMargin":-103.3,"freeCashflow":-20000000,"operatingCashflow":-1466000000,"totalDebt":1298000000,"debtToEquity":17.5,"currentRatio":2.41,"returnOnAssets":-13.1,"returnOnEquity":-36.6,"analystRating":"3.0 - Hold","recommendationKey":"hold","numberOfAnalysts":19,"targetMeanPrice":43.37,"targetHighPrice":69,"targetLowPrice":21,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":7.3,"institutionHeldPercent":77.5,"sharesOutstanding":396786259,"floatShares":370094447,"sharesShort":58309643,"shortRatio":10.34,"shortPercentOfFloat":14.7,"epsTrailing":-8.14,"epsForward":-4.16,"revenuePerShare":5.69,"bookValue":21.95,"officers":[{"age":52,"name":"Mr. Stéphane  Bancel M.B.A.","title":"CEO & Director"},{"age":49,"name":"Dr. Stephen  Hoge M.D.","title":"President"},{"age":48,"name":"Mr. James M. Mock","title":"Chief Financial Officer"},{"age":54,"name":"Ms. Shannon Thyme Klinger J.D.","title":"Chief Legal Officer & Corporate Secretary"},{"age":59,"name":"Dr. Jerh  Collins Ph.D.","title":"Chief Technical Operations & Quality Officer"},{"age":51,"name":"Ms. Lavina  Talukdar CFA","title":"Senior VP & Head of Investor Relations"},{"age":45,"name":"Ms. Tracey  Franklin","title":"Chief People & Digital Technology Officer"},{"age":null,"name":"Dr. Charbel  Haber M.P.H., Ph.D.","title":"Senior VP & Head of Global Regulatory Science"}],"industry":"Biotechnology","irWebsite":"","website":"https://www.modernatx.com","phone":"617 714 6500"}}